Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

Similar articles for PubMed (Select 23009247)

1.

A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes.

Lipsky BA, Moran GJ, Napolitano LM, Vo L, Nicholson S, Kim M.

BMC Infect Dis. 2012 Sep 25;12:227. doi: 10.1186/1471-2334-12-227.

2.

Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study.

Garau J, Ostermann H, Medina J, Avila M, McBride K, Blasi F; REACH study group.

Clin Microbiol Infect. 2013 Sep;19(9):E377-85. doi: 10.1111/1469-0691.12235. Epub 2013 May 10.

3.

Surgical site infections: does inadequate antibiotic therapy affect patient outcomes?

Eagye KJ, Kim A, Laohavaleeson S, Kuti JL, Nicolau DP.

Surg Infect (Larchmt). 2009 Aug;10(4):323-31. doi: 10.1089/sur.2008.053.

PMID:
19622027
4.

Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients.

Zervos MJ, Freeman K, Vo L, Haque N, Pokharna H, Raut M, Kim M.

J Clin Microbiol. 2012 Feb;50(2):238-45. doi: 10.1128/JCM.05817-11. Epub 2011 Nov 23.

5.

Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study.

Lipsky BA, Napolitano LM, Moran GJ, Vo L, Nicholson S, Chen S, Boulanger L, Kim M.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):266-72. doi: 10.1016/j.diagmicrobio.2014.02.013. Epub 2014 Feb 24.

PMID:
24657171
6.

How complicated skin and soft tissue infections are treated in Italy: economic evaluation of inpatient intravenous antibiotic treatment in seven hospitals.

Tarricone R, Aguzzi G, Capone A, Caravaggi CM, Esposito S, Franzetti F, Muzzi A, Ricci L, Bassetti M.

J Med Econ. 2008;11(2):265-79. doi: 10.3111/13696990802113196.

PMID:
19450085
7.

Effectiveness and safety of daptomycin in complicated skin and soft-tissue infections and bacteraemia in clinical practice: results of a large non-interventional study.

Gonzalez-Ruiz A, Beiras-Fernandez A, Lehmkuhl H, Dohmen PM, Loeffler J, Chaves RL.

Int J Antimicrob Agents. 2013 Apr;41(4):372-8. doi: 10.1016/j.ijantimicag.2012.12.017. Epub 2013 Feb 24.

PMID:
23499225
8.

Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors.

Lipsky BA, Napolitano LM, Moran GJ, Vo L, Nicholson S, Kim M.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):273-9. doi: 10.1016/j.diagmicrobio.2014.02.011. Epub 2014 Feb 24.

PMID:
24661685
9.
10.

Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies.

Bassetti M, Eckmann C, Bodmann KF, Dupont H, Heizmann WR, Montravers P, Guirao X, Capparella MR, Simoneau D, Sánchez García M.

J Antimicrob Chemother. 2013 Jul;68 Suppl 2:ii5-14. doi: 10.1093/jac/dkt140.

13.

Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies.

Montravers P, Bassetti M, Dupont H, Eckmann C, Heizmann WR, Guirao X, García MS, Capparella MR, Simoneau D, Bodmann KF.

J Antimicrob Chemother. 2013 Jul;68 Suppl 2:ii15-24. doi: 10.1093/jac/dkt141.

14.

Complicated skin and soft tissue infection.

Dryden MS.

J Antimicrob Chemother. 2010 Nov;65 Suppl 3:iii35-44. doi: 10.1093/jac/dkq302. Review.

15.

Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA) skin and soft tissue infections in the emergency department.

Walraven CJ, Lingenfelter E, Rollo J, Madsen T, Alexander DP.

J Emerg Med. 2012 Apr;42(4):392-9. doi: 10.1016/j.jemermed.2011.03.009. Epub 2011 Apr 27.

PMID:
21524884
16.

Audit of diabetic soft tissue infection and foot disease in Accra.

Asumanu E, Ametepi R, Koney CT.

West Afr J Med. 2010 Mar-Apr;29(2):86-90.

PMID:
20544632
17.

Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.

Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C; Linezolid CSSTI Study Group.

Antimicrob Agents Chemother. 2005 Jun;49(6):2260-6.

18.

Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.

Falagas ME, Barefoot L, Griffith J, Ruthazar R, Snydman DR.

Eur J Clin Microbiol Infect Dis. 1996 Dec;15(12):913-21.

PMID:
9031873
20.

Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.

McKinnon PS, Sorensen SV, Liu LZ, Itani KM.

Ann Pharmacother. 2006 Jun;40(6):1017-23. Epub 2006 May 23.

PMID:
16720705
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk